Schedule 13G ownership disclosure
RECURSION PHARMACEUTICALS INC CL A
Class A Common Stock · CUSIP: 75629V104
Event date: 2024-12-31
- Filing-level shares
- 32,346,397.00
- Percent of class
- 8.47%
- ARK Investment Management LLC
Shares: 32,346,397.00 · Class: 8.47%
Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.
Source: SEC EDGAR filingFiling metadata
- Accession number
- 0001104659-25-013686
- Form type
- SCHEDULE 13G/A
- Filer
- ARK Investment Management LLC
- CIK
- CIK 1697748
- Filed
- Feb 14, 2025
- Reporting period
- Dec 31, 2024
- Description
- Schedule 13G beneficial ownership